info@p-95.com

Clinical Trial Delivery

Comprehensive Clinical Trial Support for Vaccines and Infectious Disease.

Data, Analysis and writing

Our data management, biostatistics, safety management and medical writing teams ensure data integrity and insightful analysis for vaccines and drugs across all stages of development.

Epidemiology and Real-World Evidence (RWE) Solutions

Comprehensive Epidemiology and RWE solutions for Vaccines and Infectious Diseases.

Africa and LMICs

Expanding Clinical and Epidemiological Horizons: Expertise in Africa, LMICs, and Beyond.

VIEW ALL SERVICES

Pallas Health Research and Consultancy:  A Legacy Continued Within P95

Pallas Health Research and Consultancy was a Dutch research and advisory organization specializing in epidemiology, public health, evidence-based medicine, and healthcare policy. For more than 25 years, Pallas supported governments, research institutions, healthcare organizations, and industry partners through scientific research, policy development, and evidence generation. Since 2021, Pallas has been part of P95.

Honouring the Pallas Legacy

Since joining P95, Pallas has become part of a global organization dedicated to advancing high-quality clinical, epidemiological, and public health research.

This page honours the history, expertise, and people behind Pallas and explains how its legacy continues today within P95.

Pallas at a Glance

  • Founded: More than 25 years ago
  • Headquarters: Rotterdam, Netherlands
  • Core expertise: Epidemiology, Public Health, Evidence-Based Medicine, Healthcare Policy
  • Research specialties: Literature Reviews, Real-World Evidence, Health Surveys, Data Analysis
  • Key clients: EFSA, ECDC, RIVM, ZonMw, Dutch Ministry of Health, universities, healthcare organizations, pharmaceutical companies
  • Integrated into P95: 2021

Advancing Evidence-Based Public Health

For more than two decades, Pallas helped organizations translate complex public health and healthcare challenges into actionable evidence, policy recommendations, and practical solutions.

Built on a foundation of scientific rigor and methodological excellence, Pallas supported decision-makers across healthcare, public health, and life sciences through research, evaluation, and strategic advisory services.

Its multidisciplinary team brought together expertise in epidemiology, health sciences, nutrition science, public health, and healthcare research, enabling projects that ranged from local healthcare improvement initiatives to international evidence reviews and policy studies.

Research, Policy, and Public Health Impact

Over the years, Pallas developed expertise across a broad range of public health and healthcare disciplines, including:

  • Systematic Literature Reviews and Meta-Analyses
  • Real-World Evidence (RWE) Studies
  • Health Technology Assessment Support
  • Healthcare Policy and Guideline Development
  • Qualitative and Quantitative Research
  • Health Surveys and Population Studies
  • Data Analysis and Epidemiological Research

Its work informed policy development, clinical practice, healthcare quality improvement, and public health decision-making at both national and international levels.

Trusted by Leading Public Health Organizations

A defining characteristic of Pallas was its ability to combine scientific excellence with practical policy relevance.

Over the years, Pallas worked with numerous national and international organizations, including the European Food Safety Authority (EFSA), the European Centre for Disease Prevention and Control (ECDC), the Dutch National Institute for Public Health and the Environment (RIVM), ZonMw, universities, healthcare institutions, professional associations, and pharmaceutical companies.

This breadth of collaboration reflects the trust placed in Pallas as a partner for evidence generation, evaluation, and strategic research.

From Public Health Research to Global Impact

In 2021, Pallas joined P95, creating new opportunities to combine expertise in public health, epidemiology, infectious diseases, and vaccination research.

The integration strengthened P95’s ability to support clients across the full research continuum—from evidence generation and epidemiological studies to policy development, scientific communications, and public health strategy.

Recent Publications

Andani, A., Mellou, K., Dewda, P., Eeuwijk, J., Kassianos, G., Van Damme, P., & Steffen, R. (2025). Evolution and Impact of Hepatitis A Epidemiology in Europe—Systematic Literature Review of the Last 20 Years. Journal of Viral Hepatitis, 32(1), e14030.

Evidence-Based Richtlijn Skin tears. V&VN, februari 2025 [Guideline Skin tears]

Evidence-Based Richtlijn Continentie bij (kwetsbare) ouderen . V&VN, april 2025 [Guideline Continence in (frail) older adults]

Marijam A, Vroom N, Bhavsar A, Posiuniene I, Lecrenier N, Vroling H. Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK. Infect Dis Ther. 2024 May;13(5):1083-1104. doi: 10.1007/s40121-024-00963-w. Epub 2024 Apr 24.

Eeuwijk J, Ferreira G, Yarzabal JP, Robert-Du Ry van Beest Holle M. A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States. Infect Dis Ther. 2024 Feb;13(2):273-298. doi: 10.1007/s40121-024-00919-0. Epub 2024 Feb 13.

Jennifer Eeuwijk en Lotte Mathé. Inventarisatie van ZonMw- en NWO gefinancierd onderzoek naar effecten van COVID-19 maatregelen. Epidemiologische effecten 13 februari 2024. In opdracht van ZonMw [Overview of ZonMw- and NWO-Funded Research on the Epidemiological Effects of COVID-19 Measures]

Eeuwijk J, Vroom N. Advies: kwetsbaarheid in de wijkverpleging – Knelpuntenanalyse. Juli 2022 [Recommendations: Frailty in community care – An Analysis of Barriers and Challenges]

Anouk Oordt, Jennifer Eeuwijk, Eveline Bunge, Valérie Wester, Philip Klein, Tim Kanters, Carin Uyl-de Groot. Medical cannabis for treating various symptoms in Switzerland. HTA report. Bundesamt für Gesundheit Sektion Health Technology Assessment. April 2021

Pallas Today, Within P95

Today, the expertise and values that defined Pallas continue within P95.

Its commitment to scientific rigor, evidence-based decision-making, and public health impact remains central to the work we do today, helping governments, healthcare organizations, researchers, and industry partners address complex health challenges around the world.

Continuing the Work at P95

The expertise, experience, and values that shaped Pallas remain central to the work we do at P95 today.

Looking for the epidemiology, public health, or evidence-generation expertise that Pallas was known for? That work continues at P95.

Explore P95 Public Health and Epidemiology Services

This page is part of the P95 Heritage Series, documenting the history of organisations that now form the P95 group. It has been prepared by P95 to honour the people, expertise, and legacy of Pallas Health Research and Consultancy.

 

 

 

P95

Pioneering Clinical Excellence in Vaccines and Infectious Diseases

Tags:

0 Comments

You May Also Like